Diabetes mellitus: an important risk factor for reactivation of tuberculosis

por Solá, Ernesto, Rivera, Carmen, Mangual, Michelle, Martinez, José, Rivera, Kelvin, Fernandez, Ricardo
Publicado 2016

SUN-155 Clinical Experience of SGLT2 Inhibitors in a Hispanic Population: Should We Consider Its Use as Add-On Treatment?

por Zayas, Francisco, Iriarte, R, Vergne, Norma, Hernandez, Luis, Gonzalez, Alex, Mangual, Michelle
Publicado 2019